Dr Reddy's Laboratories may test Rs 3350-:- Equity Research

Rajat Bose of rajatkbose.com told CNBC-TV18, "Technicals are sort of becoming better because Dr Reddy's Laboratories had a big fall after it has posted very bad results and this went down below Rs 3,000 levels but did not really go to the target levels mentioned by a lot of analysts like Rs 2,700 or so." "From here, if it were to cross Rs 3,150, it will gain traction. That is still 75 points to go and after that the next target would be Rs 3,350. So, that is a medium-term target for this stock and put a stoploss below Rs 2,925," he added. The share touched its 52-week high Rs 4,382.95 and 52-week low Rs 2,750 on 20 October, 2015 and 21 January, 2016, respectively.